22.01.2020 • News

BASF Upgrades Polyacrylates at Ludwigshafen

BASF Upgrades Polyacrylates at Ludwigshafen (c) BASF
BASF Upgrades Polyacrylates at Ludwigshafen (c) BASF

With a “single-digit million-euro” investment, BASF has improved the flexibility of its water-soluble polyacrylates plant at its Ludwigshafen, Germany, headquarters site and expanded capacity slightly. Details have not been provided.

The world’s largest chemical producer said the facility is now up and running and supplying customers in the household and commercial cleaning products, as well as in chemical and formulator industries.

"High-performance water-soluble polyacrylates and copolymers are an indispensable component of our customers' formulations. With this investment and our applications expertise, we are supporting our European customers in their efforts to boost their market growth with differentiated products," said Soeren Hildebrandt, senior vice president, Home Care, I&I and Industrial Formulators Europe.

BASF’s water-soluble polyacrylates and copolymers are marketed by its Care Chemicals operating division under the Sokalan brand name and have numerous applications in the household and commercial cleaning products industry for water softening and in various technical processes, for example to prevent fouling.

As dye transfer inhibitors, Sokalan branded products also protect fabrics from discoloration during washing. The narrow molecular weight distribution of the latest class of polyacrylates makes them highly effective as mineral dispersing agents, BASF said.

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.